[ad_1] Securities Class Action Pending Over Key Drug’s Efficacy SAN FRANCISCO, Dec. 1, 2025 /PRNewswire/ — Global plaintiffs’ rights law firm Hagens Berman reminds investors of the December 8, 2025, deadline to move the Court […]
Tag: Hagens Berman Sobol Shapiro LLP
James Hardie Industries (JHX) CFO Replaced, Lawsuit Alleging Securities Fraud Over Inventory Misstatements Pending — Hagens Berman
[ad_1] SAN FRANCISCO, Dec. 1, 2025 /PRNewswire/ — On November 17, 2025, James Hardie Industries plc (NYSE: JHX) announced the departure of its CFO (Rachel Wilson) who was immediately replaced by outsider Ryan Lada. This […]
Primo Brands (PRMB) Faces Securities Class Action Following Revelations of Integration Failure and 36% Stock Crash
[ad_1] Hagens Berman Urges PRMB Investors to Contact the Firm SAN FRANCISCO, Dec. 1, 2025 /PRNewswire/ — Investor rights law firm Hagens Berman reminds investors of the January 12, 2026, deadline to move the Court […]
Investors Face Jan. 12 Lead Plaintiff Deadline
[ad_1] Hagens Berman Investigates Claims Stride Misled Investors About “Ghost Students” and Poor Customer Experience SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — Investor rights law firm Hagens Berman reminds investors of the January 12, 2026, […]
Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman
[ad_1] TLX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the […]
